Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the treatment of type 2 diabetes. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://andrewtudg966719.blogrenanda.com/45713458/semaglutide-a-potential-solution-for-obesity